Hepatitis E in transfusion‐dependent thalassaemia patients, in Greece: a single centre experience | Zendy

Klonizakis P. | Zendy; Gioula G. | Zendy; Exindari M. | Zendy; Apostolou C. | Zendy; Kotsiafti A. | Zendy; Vlachaki E. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Hepatitis E in transfusion‐dependent thalassaemia patients, in Greece: a single centre experience

Author(s) -

Klonizakis P.,

Gioula G.,

Exindari M.,

Apostolou C.,

Kotsiafti A.,

Vlachaki E.

Publication year - 2017

Publication title -

vox sanguinis

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.68

H-Index - 83

eISSN - 1423-0410

pISSN - 0042-9007

DOI - 10.1111/vox.12572

Subject(s) - medicine , hepatitis , hepatitis e virus , blood transfusion , disease , thalassemia , hepatitis c , hepatitis e , hepatitis c virus , viral hepatitis , immunology , virus , pediatrics , virology , biology , biochemistry , genotype , gene

Hepatitis E is considered an emerging disease that may be a threat in both developing and industrialized countries all over the world. The risk of chronic hepatitis E virus infection is higher among immunocompromised patients. This study aimed to assess the status of hepatitis E infection in patients with transfusion‐dependent thalassaemia from a single centre, in Greece. Our results suggest that the prevalence of hepatitis E infection in this group of patients is low.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research